Testing effectiveness (Phase 2)Study completedNCT01876381
What this trial is testing
A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
Who this might be right for
Chronic Renal Failure
Otsuka Pharmaceutical Co., Ltd. 26